Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Daniel Francis Kiernan , MD

Ophthalmology • Sarasota, FL

Active NPI 1376790022 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

2111 Bee Ridge Rd
Sarasota, FL 342396104

Call 9417922020 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

2111 Bee Ridge Rd

Sarasota, FL 342396104

Telephone 9417922020
Organization at the Same NPPES Address or Phone
Robert L. Kantor, Md,pa Facility NPI 1013935543

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

NPPES lists 8 distinct additional practice-address records in Bradenton, FL; Ellenton, FL; Fort Myers, FL and 3 more. See the list

Source: CMS NPPES NPI Registry, practice location records; release date unavailable.

CMS Doctors and Clinicians lists 1 group name: Retina Partners Of Florida. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

Chicago College Of Medicine And Surgery

Graduation Year

2005

Medicare patients

980 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $4,970,858 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $3,923,888 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,314 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$47,950 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $89,399.89 across 97 records.

By nature of payment (3 largest of 6)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $60,953.68 across 14 records.
  • Honoraria: $14,175.00 across 2 records.
  • Grant: $5,199.00 across 1 record.

Reporting-company totals (3 largest of 14)

  • Regeneron Pharmaceuticals, Inc.: $32,622.14 across 30 records.
  • Mallinckrodt Hospital Products Inc.: $31,989.05 across 24 records.
  • ANI Pharmaceuticals, Inc.: $15,603.31 across 12 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

21 years (graduated 2005)

CMS Doctors and Clinicians data list 2005 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2008

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Kiernan has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Kiernan as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Sarasota and Florida

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 85% of clinicians listed under Ophthalmology in Sarasota, FL (2024, 22 clinicians with data). Median for this group: 3,584. Middle half: 1,936 to 13,930.

More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: 2,189. Middle half: 818 to 4,724.

Medicare-allowed amount

A higher Medicare-allowed amount than 90% of clinicians listed under Ophthalmology in Sarasota, FL (2024, 22 clinicians with data). Median for this group: $386,753. Middle half: $222,336 to $643,131.

A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: $242,390. Middle half: $87,419 to $538,035.

Paid by Medicare

A higher Medicare payment amount than 90% of clinicians listed under Ophthalmology in Sarasota, FL (2024, 22 clinicians with data). Median for this group: $283,186. Middle half: $158,104 to $490,450.

A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Florida (2024, 1,013 clinicians with data). Median for this group: $175,695. Middle half: $62,701 to $392,398.

Medicare Part D prescriptions

Close to the middle for clinicians listed under Ophthalmology in Sarasota, FL (2024, 22 clinicians with data). Median for this group: 990. Middle half: 519 to 1,417.

Close to the middle for clinicians listed under Ophthalmology in Florida (2024, 1,099 clinicians with data). Median for this group: 1,203. Middle half: 441 to 2,500.

Part D drug cost

Close to the middle for clinicians listed under Ophthalmology in Sarasota, FL (2024, 22 clinicians with data). Median for this group: $97,033. Middle half: $28,583 to $121,075.

A lower Part D drug cost than 65% of clinicians listed under Ophthalmology in Florida (2024, 1,099 clinicians with data). Median for this group: $115,029. Middle half: $23,964 to $310,282.

29 active clinicians are listed under Ophthalmology with a practice address in Sarasota, FL (1,584 in Florida).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Sarasota

3.4% of these 29 clinicians have the CMS telehealth indicator.

72.4% of these 29 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 97 records totaling $89,399.89.

Manufacturer Payment Nature Product Type Amount ($)
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $11,050.00
ANI Pharmaceuticals, Inc.
Honoraria
Cash or cash equivalent
PURIFIED CORTROPHIN GEL General $10,125.00
Mallinckrodt Hospital Products Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ACTHAR General $9,300.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $6,630.00
Mallinckrodt Hospital Products Inc.
Grant
Cash or cash equivalent
ACTHAR General $5,199.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $4,973.00
Mallinckrodt Hospital Products Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ACTHAR General $4,650.00
ANI Pharmaceuticals, Inc.
Honoraria
Cash or cash equivalent
PURIFIED CORTROPHIN GEL General $4,050.00
Mallinckrodt Hospital Products Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ACTHAR General $3,100.00
Mallinckrodt Hospital Products Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ACTHAR General $3,100.00
Mallinckrodt Hospital Products Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ACTHAR General $3,100.00
ABBVIE INC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
OZURDEX General $3,000.00
ABBVIE INC.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
OZURDEX General $3,000.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $2,763.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $2,711.85
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EYLEA HD General $2,025.83
ABBVIE INC.
Consulting Fee
Cash or cash equivalent
OZURDEX General $2,000.00
Mallinckrodt Hospital Products Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
ACTHAR General $1,550.00
ANI Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
PURIFIED CORTROPHIN GEL General $710.78
Mallinckrodt Hospital Products Inc.
Travel and Lodging
In-kind items and services
ACTHAR General $542.36
Mallinckrodt Hospital Products Inc.
Travel and Lodging
Cash or cash equivalent
ACTHAR General $394.62
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $296.40
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $265.20
Mallinckrodt Hospital Products Inc.
Travel and Lodging
In-kind items and services
ACTHAR General $251.63
Regeneron Pharmaceuticals, Inc.
Travel and Lodging
In-kind items and services
EYLEA HD General $248.48

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
J2777 Injection, faricimab-svoa, 0.1 mg
17,760 102 $83.66 $34.10
J0177 Injection, aflibercept hd, 1 mg
3,816 115 $756.73 $309.75
J2782 Injection, avacincaptad pegol, 0.1 mg
3,200 37 $238.87 $108.05
J2781 Injection, pegcetacoplan, intravitreal, 1 mg
3,030 32 $362.85 $147.64
92134 Imaging of retina
2,284 891 $77.69 $39.32
67028 Injection of drug into eye
1,638 403 $694.06 $129.78
J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
1,600 13 $1.64 $0.69
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
1,549 836 $253.38 $128.74
J0178 Injection, aflibercept, 1 mg
1,144 144 $1799.68 $821.28
92201 Extended exam of the back part of the eye with retinal drawing
355 341 $64.89 $24.61
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg
280 24 $380.86 $202.30
J3590 Unclassified biologics
238 92 $6222.69 $2685.29
92235 Exam of retinal blood vessels using a special camera after injection of a dye
187 177 $228.01 $157.28
92250 Photography of the retina
167 130 $71.49 $35.88
92273 Measurement of retinal and optic nerve function
164 145 $250.00 $121.80
76512 2d ultrasound scan of eye tissue and structures
157 104 $93.46 $46.76
92014 Established patient complete exam of visual system
154 124 $250.00 $123.05
J2778 Injection, ranibizumab, 0.1 mg
126 15 $487.84 $145.35
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99 99 $252.36 $169.05
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
75 69 $154.53 $91.83
J7999 Compounded drug, not otherwise classified
68 30 $123.76 $76.94
67041 Removal of membrane of retina
51 43 $2237.51 $1124.91
68841 Insertion of drug delivery implant into tear duct of eye
49 40 $95.00 $19.12
67113 Complex repair of detached retina and drainage of eye fluid between lens and retina
35 25 $3233.00 $1131.97
67145 Photocoagulation treatment to prevent detachment of retina
29 26 $587.44 $233.12

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Prednisolone Acetate Prednisolone Acetate 377 12,702 $14,637.56 210
Ofloxacin Ofloxacin 204 5,091 $2,653.99 167
Ketorolac Tromethamine Ketorolac Tromethamine 83 2,287 $1,398.88 38
Atropine Sulfate Atropine Sulfate 81 3,496 $3,436.02 55
Combigan Brimonidine Tartrate/Timolol 38 1,757 $8,964.67 17
Brimonidine Tartrate Brimonidine Tartrate 37 1,296 $626.26 14
Dorzolamide Hcl Dorzolamide Hcl 30 1,675 $434.53 15
Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol 29 1,241 $2,817.80 12
Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat 21 1,562 $169.50 11
Latanoprost Latanoprost 20 1,295 $192.38 —
Lumigan Bimatoprost 17 865 $7,887.67 —
Difluprednate Difluprednate 16 353 $1,780.78 —
Timolol Maleate Timolol Maleate 15 817 $30.59 —
Bromsite Bromfenac Sodium 11 320 $2,919.29 —

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2024-09-09
Ophthalmology Primary Specialty

NUCC Taxonomy Code: 207W00000X

License # reported to NPPES NY 261453

An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Florida Department of Health Medical Quality Assurance.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
03338727 (NY)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - OPHTHALMOLOGY

Medicare Enrollment ID

I20200923000687

Enrollment State Jurisdiction

FL

PECOS Control ID

4981757432

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Retina Partners Of Florida

2322 Lakeland Hills Blvd, Lakeland, FL 338052995

Phone: 8633454350

Retina Partners Of Florida

410 1st St S, Winter Haven, FL 338803504

Phone: 8633454350

Secondary Practice Locations

6002 Pointe West Blvd

Bradenton, FL 342095531

Phone: 9417922020

1601 38th Ave N

St Petersburg, FL 337131926

Phone: 9417922020

1550 E Venice Ave

Venice, FL 342921661

Phone: 9417922020

4101 Evans Ave

Fort Myers, FL 339019310

Phone: 9417922020

3894 Sun City Center Blvd

Sun City Center, FL 335736806

Phone: 9417922020

7915 Us Highway 301 N Ste 101

Ellenton, FL 342223532

Phone: 9417922020

6807 State Road 70 E

Bradenton, FL 342039743

Phone: 9417922020

2203 61st St W

Bradenton, FL 342095528

Phone: 9417922020

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

34 listed
NPI 1649492711

Doctor of Medicine (M.D.)

NPI 1851361059

Doctor of Optometry

NPI 1205836418

Doctor of Medicine (M.D.)

NPI 1427056365

Doctor of Optometry

NPI 1962409896

Doctor of Medicine (M.D.)

Robert Davis

Ophthalmology

NPI 1295184158

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

24 Historical Events
🏢
Secondary Practice Location Registered September 09, 2024

Additional practice office at 4101 Evans Ave, Fort Myers, FL 339019310

🏢
Secondary Practice Location Registered September 09, 2024

Additional practice office at 3894 Sun City Center Blvd, Sun City Center, FL 335736806

🏢
Secondary Practice Location Registered September 09, 2024

Additional practice office at 1601 38th Ave N, St Petersburg, FL 337131926

🏢
Secondary Practice Location Registered September 09, 2024

Additional practice office at 6002 Pointe West Blvd, Bradenton, FL 342095531

🏢
Secondary Practice Location Registered September 09, 2024

Additional practice office at 6807 State Road 70 E, Bradenton, FL 342039743

🏢
Secondary Practice Location Registered September 09, 2024

Additional practice office at 1550 E Venice Ave, Venice, FL 342921661

🏢
Secondary Practice Location Registered September 09, 2024

Additional practice office at 2203 61st St W, Bradenton, FL 342095528

🏢
Secondary Practice Location Registered September 09, 2024

Additional practice office at 7915 US Highway 301 N Ste 101, Ellenton, FL 342223532

📍
Updated Practice Location June 17, 2024

Registered at 2111 BEE RIDGE RD, SARASOTA, FL 342396104 (Tel: 9417922020)

📍
Updated Business Mailing Address June 17, 2024

Registered at PO BOX 162264, ALTAMONTE SPRINGS, FL 327162264 (Tel: 9417922020)

📍
Updated Practice Location September 09, 2020

Registered at 6002 POINTE WEST BLVD, BRADENTON, FL 342095531 (Tel: 9417922020)

📍
Updated Business Mailing Address September 09, 2020

Registered at 6002 POINTE WEST BLVD, BRADENTON, FL 342095531 (Tel: 9417922020)

📍
Updated Business Mailing Address September 16, 2019

Registered at 825 E GATE BLVD STE 111, GARDEN CITY, NY 115302136 (Tel: 5168045200)

✅
NPI Profile Active March 23, 2017

NPI status registered as active in NPPES database

📍
Updated Practice Location March 23, 2017

Registered at 2000 N. VILLAGE AVENUE, SUITE 402, ROCKVILLE CENTRE, NY 11570 (Tel: 5167662519)

📍
Updated Business Mailing Address March 23, 2017

Registered at 865 MERRICK AVENUE, SUITE 80N, WESTBURY, NY 115906695 (Tel: 5168045200)

👤
Provider Name / Credentials Updated March 23, 2017

Recorded as DANIEL KIERNAN, MD

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) March 23, 2017

Ophthalmology (license number reported to NPPES: NY 261453)

✅
NPI Profile Active April 03, 2012

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) April 03, 2012

Registered at 2000 N. VILLAGE AVENUE, SUITE 402, ROCKVILLE CENTRE, NY 11570 (Tel: 5167662519)

📍
Business Mailing Address (Initial Record) April 03, 2012

Registered at 865 MERRICK AVENUE, SUITE 80N, WESTBURY, NY 115906695 (Tel: 5168045200)

👤
Provider Name / Credentials (Initial Record) April 03, 2012

Recorded as DANIEL KIERNAN, MD

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) April 03, 2012

Ophthalmology (license number reported to NPPES: NY 261453)

🟢
Initial NPI Registration & Enumeration August 25, 2008

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1376790022
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: August 25, 2008
Last Update: September 09, 2024
Sole Proprietor: No

Other Ophthalmology Specialists in Sarasota

All Ophthalmology Specialists in Sarasota

Mailing Address

Po Box 162264

Altamonte Springs, FL 327162264

Phone: 9417922020

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.